A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Clinical trial NCT01049035 · COMPLETED

Trial details

NCT number: NCT01049035
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis Meningococcal Infection

Start date: 2009-12-16
Primary completion: 2012-02-13
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.